The All Ordinaries Index (ASX: XAO) fell 0.65% today, but three ASX shares charged higher.
The Magnis Energy Technologies Ltd (ASX: MNS), Cettire Ltd (ASX: CTT) and Avita Medical Inc (ASX: AVH) share prices all outperformed the index today.
Let's take a look at what impacted these three ASX All Ordinaries shares.
Magnis Energy
The Magnis Energy Technologies share price climbed 1.25% today despite no news from the company. However, Magnis' US traded OTC shares (OTC: MNSEF) climbed 2.32% overnight.
Magnis is a lithium-ion battery company with investments in lithium-ion battery cells, lithium-ion battery technology and high-performance anode materials. The company is invested in large-scale lithium-ion battery cell manufacturing projects in New York and Townsville, Queensland. In a recent investment presentation, Magnis highlighted the New York lithium battery facility has commenced commercial production. The facility is expected to produce about 15,000 cells a day at capacity.
Cettire
This company's shares leapt 2.10% today. Cettire is a global luxury online retailer. In today's news, Cettire has signed a commercial agreement with Zegna Group. Under the deal, Cettire will be able to integrate and sell products from Zegna on its platform. Customers of Cettire will have access to Zegna products in all of Cettire's markets.
Commenting on the news, Cettire CEO and founder Dean Mintz said:
We are excited about our newly announced agreement with Zegna. Zegna is a world-renowned brand with a rich history originating in the heart of the luxury fashion industry.
With this collaboration, Cettire enables Zegna's products to be directly available to a new and fast growing audience of luxury customers.
Avita Medical
Avita Medical shares jumped 1.94% today. In contrast, the ASX 200 Health Care Index (ASX: XHJ) fell 0.78%. Avita is working on a burn treatment device known as the Recell system.
Avita held its annual general meeting this week. Chairman Lou Panaccio said the company continues to be in a "strong position" when it comes to growth into new markets, corporate health and financial position. He highlighted Avita had more than US$88 million in cash reserves as at 30 September.
